However, these findings are in conflict with those by Kume et al. (2009a, b), in which, although reporting that RTN3 subcellularly co-localizes with BACE1, no significant differences in its expression levels were observed between control and AD brains. The gene discussed is RTN3; the disease is Alzheimer disease.